Board Meeting Details
- Meeting Date: Thursday, 5th November, 2026
- Meeting Location: Registered Office of the Company
- Primary Agenda: Consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026
- The document specifies "inter-alia" indicating there may be additional agenda items
Filing Details
- Reference Number: SFIL/COSEC/BSE/Q3/BM5/2910/2026-27
- Submission Date: Thursday, 29th October, 2026
- Digital signature timestamp: 2026.10.29 14:49:30 +0530 and 2026.10.29 14:50:05 +05'30'
Financial Impact
Financial impact not quantified in this disclosure. The meeting is scheduled to review and approve financial results for Q2 FY27 (quarter ended September 30, 2026).